The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2020
Filed:
May. 18, 2018
Applicant:
Longhorn Vaccines and Diagnostics, Llc, Bethesda, MD (US);
Inventors:
Gerald W. Fischer, Bethesda, MD (US);
Luke T. Daum, San Antonio, TX (US);
Assignee:
Longhorn Vaccines and Diagnostics, LLC, Bethesda, MD (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/145 (2006.01); C07K 14/35 (2006.01); C07K 14/005 (2006.01); C07K 16/12 (2006.01); C07K 16/10 (2006.01); A61K 39/04 (2006.01); C12N 7/00 (2006.01); A61K 39/12 (2006.01); C07K 14/33 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 39/04 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 14/33 (2013.01); C07K 14/35 (2013.01); C07K 16/1018 (2013.01); C07K 16/1289 (2013.01); C12N 7/00 (2013.01); A61K 2039/525 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/53 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6043 (2013.01); A61K 2039/6068 (2013.01); A61K 2039/70 (2013.01); C07K 2319/40 (2013.01); C07K 2319/42 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16161 (2013.01);
Abstract
The invention relates to composite antigens comprising a peptide with contiguous amino acid sequence derived from a plurality of antigenic epitopes of one or more pathogens that induces an immune response in a mammal that is protective against infection by the one or more pathogens. In addition, the invention relates to vaccines comprising composite antigens and to method for treating and preventing an infection.